Electrocardiographic profile of oral piperazine citrate in healthy volunteers

American Journal of Therapeutics

Volumn 13, Issue 1, 2006, Pages 43-47

  Onuaguluchi, Gilbert ^a   Ghasi, Samuel ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Electrocardiography; Healthy volunteers; Piperazine

Indexed keywords

PIPERAZINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ELECTROCARDIOGRAPHY; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; P WAVE; PRIORITY JOURNAL; QRS COMPLEX; SINUS RHYTHM; STATISTICAL ANALYSIS;

ADULT; ANTHELMINTICS; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; PIPERAZINES; REFERENCE VALUES; VENTRICULAR FUNCTION;

EID: 31544454740     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000151860.52074.5f     Document Type: Article

References (17)

1. Brown HW, Chan K-F, Hussey KL. Treatment of enterobiasis and ascariasis with piperazine. JAMA. 1956;161:515-520.
2. Mansour TE. Chemotherapy of parasitic worms: new biochemical strategies. Science. 1979;205:462-469.
3. Del Castillo J, de Mello WC, Morales T. Mechanism of the paralyzing actions of piperazine on ascaris muscle. Br J Pharmacol Chemother. 1964;22:463-477.
4. Norton S, de Beer EJ. Investigations of the action of piperazine on Ascaris lumbricoides. Am J Trop Hyg. 1957;6:898-905.
5. Onuaguluchi G. Some aspects of the pharmacology of piperazine citrate and the antiascaris fraction of the ethanolic extract of the bark of the ERIN tree (Polyadoa umbellata- Dalziel). West Afr Med J. 1966;15:22-25.
6. Onuaguluchi G. Effect of the antiascaris fraction of the ethanolic extract of the bark of Polyadoa umbellata (Erin) and of piperazine citrate on mammalian non-vascular smooth muscle. Pharmacologist. 1981;23:45.
7. Onuaguluchi G. Effect of piperazine citrate and of the antiascaris fraction of the ethanolic extract of the bark of Polyadoa umbellata (ERIN) on mammalian non-vascular smooth muscle. Arch Int Pharmacodyn Ther. 1984;269:263-270.
8. Onuaguluchi G, Igbo INA. Comparative antiarrhythmic and local anaesthetic effects of piperazine citrate and lignocaine hydrochloride. Arch Int Pharmacodyn Ther. 1985;274:253-266.
9. Gijsman HJ, Van Geerven JM, Tieleman MC, et al. Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers. J Clin Psychopharmacol. 1998;18:289-295.
10. Burch GE, Winsor T. A Primer of Electrocardiography, 5th ed. Philadelphia: Lea and Febiger; 1969:67-145.
11. Bigger JT, Hoffman BF. Antiarrhythmic drugs. In: Gilman AC, Goodman LS, Gilman A. eds. Pharmacological Basis of Therapeutics, 8th ed. New York: Macmillan; 1992:840-873.
12. Dressel PE. Antiarrhythmic drugs. In: Pradhan SN, Dutta SN, eds. Pharmacology in Medicine - Principles and Practice. Bethesda, MD: SP Press International; 1986:572-583.
13. Murray FT. Ibutilide. Circulation. 1998;97:493-497.
14. Torp-Pedersen C, Moller M, Bloch-Thomsen PF, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med. 1999;341:857-865.
15. Roden DM. Antiarrhythmic drugs. In: Hardman JG, Limbird LE, Gilman AG, eds. The Pharmacological Basis of Therapeutics, 10th ed. New York: McGraw-Hill; 2001:933-970.
16. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation. 1991;84:1831-1851.
17. Singh BN. Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact. Eur Heart J. 1993;14(suppl. H):14-23.